Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion

Overview of attention for article published in Frontiers in immunology, December 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 6 publications that cite this research output.

6

The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.

Aging-related biomarker discovery in the era of immune checkpoint inhibitors for cancer patients

Article in Frontiers in Immunology (March 2024)

Elevated Galectin-9 across the human brain correlates with HIV neuropathology and detrimental cognitive states

Article in Journal of NeuroVirology (May 2023)

Galectin-9 and PD-L1 antibody blockade combination therapy inhibits tumour progression in pancreatic cancer

Article in Immunotherapy (February 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.